Inhalation Sciences Sweden AB (publ) (XSAT:ISAB)
Sweden · Delayed Price · Currency is SEK 0.1805
-0.0045 (-2.43%)
At close: Aug 6, 2026
XSAT:ISAB Revenue
Inhalation Sciences Sweden AB had revenue of 937.00K SEK in the twelve months ending March 31, 2026.
Revenue (ttm)
937.00K
Revenue Growth
-19.62%
P/S Ratio
1.45
Revenue / Employee
1.28M
Employees
5
Market Cap
9.24M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 11.05M | -6.46M | -36.89% |
| Dec 31, 2023 | 17.50M | 5.31M | 43.55% |
| Dec 31, 2022 | 12.19M | 2.77M | 29.42% |
| Dec 31, 2021 | 9.42M | -715.00K | -7.05% |
| Dec 31, 2020 | 10.14M | 1.19M | 13.28% |
| Dec 31, 2019 | 8.95M | 3.51M | 64.47% |
| Dec 31, 2018 | 5.44M | -2.58M | -32.17% |
| Dec 31, 2017 | 8.02M | 806.00K | 11.17% |
| Dec 31, 2016 | 7.22M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Exalt AB | 45.66M |
| Risk Intelligence | 39.62M |
| Stockholm Treasury AB | 16.34M |
| Windon Energy Group AB | 14.98M |
| Tessin Nordic Holding AB | 11.59M |
| Monivent AB | 4.77M |
| Biofrigas Sweden AB | 469.78K |
| C100 AB | -78.00 |
Inhalation Sciences Sweden AB News
- 6 weeks ago - Inhalation Sciences Sweden AB Annual report - Filings
- 6 weeks ago - Inhalation Sciences Sweden AB Annual report - Filings
- 6 weeks ago - Inhalation Sciences Sweden AB Annual report - Filings
- 6 weeks ago - Inhalation Sciences Sweden AB Annual report - Filings
- 6 weeks ago - Inhalation Sciences Sweden AB Annual report - Filings
- 6 weeks ago - Inhalation Sciences Sweden AB Annual report - Filings
- 6 weeks ago - Inhalation Sciences Sweden AB Annual report - Filings
- 6 weeks ago - Inhalation Sciences Sweden AB Quarterly report - Filings